Clinical Trial Update: Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating whether S-adenosylmethionine (SAMe) affects blood homocysteine levels in people with hyperhomocysteinemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhomocysteinemia

Drugs mentioned

• S-Adenosyl-L-Methionine (SAMe) (S-adenosyl-L-methionine)

Snippet

Sponsor: Baylor Research Institute | Conditions: Hyperhomocysteinemia | Phase 1 | Status: COMPLETED